Target intelligence / Profile preview

Non-specific proteins and biomolecules at polymer–biological interfaces

Molecular classification
Other
01

Overview

Non-specific proteins and biomolecules at polymer–biological interfaces refer to the complex layer of biological entities that spontaneously adsorb onto synthetic surfaces upon exposure to physiological environments. This phenomenon, frequently termed protein corona formation in the context of nanoparticles, dictates the biological identity and subsequent fate of the material in vivo (Walkey & Chan, 2012, doi:10.1021/cr200432e). These interactions are often governed by the Vroman effect, where high-abundance proteins initially bind and are later replaced by high-affinity proteins (Vroman, 1962). While not a traditional drug target, these interfaces are central to the success of medical implants and nanocarriers, as they can trigger the foreign body response, inflammation, and thrombosis (Anderson et al., 2008, doi:10.1016/j.semimmun.2008.01.004). Therapeutic strategies focus on stealth modifications, such as PEGylation or zwitterionic coatings, to minimize non-specific binding and evade immune detection (Lowe et al., 2015, doi:10.1038/nmat4444). Understanding these interfaces is crucial for improving the biocompatibility and pharmacokinetic profiles of advanced therapeutic systems. The composition of this interface can vary significantly based on the polymer's surface chemistry, charge, and hydrophobicity, making the biological response difficult to predict without detailed characterization.

Other names
Protein coronaNon-specific protein adsorptionBiofoulingVroman effectSurface-adsorbed biomoleculesBiomolecular corona
02

Mechanism of action

Prevention of non-specific adsorption through steric hindrance or the formation of a dense hydration layer to minimize surface energy and biological recognition.

03

Biological functions

Protein adsorptionOpsonizationSurface conditioningImmune recognitionCell adhesion
04

Disease associations

InflammationForeign body responseThrombosisInfectionFibrosis
05

Safety considerations

Accelerated blood clearance (ABC) phenomenonImmunogenicityFibrosisThrombus formationComplement activation-related pseudoallergy (CARPA)
06

Interacting drugs

Polyethylene glycol

4 more in the full profile.

07

Biomarkers

Complement C3FibrinogenAlbuminImmunoglobulin GApolipoprotein E

Beyond the preview

Go deeper on Non-specific proteins and biomolecules at polymer–biological interfaces.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-specific proteins and biomolecules at polymer–biological interfaces.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call